COVID-19 has changed the world we know and will continue to do so for a while. Right now, we experience unprecedented times that have already forced us to adapt to change (e.g. remote working) and we will have to stay flexible for further adjustments if we want to come out of this stronger and successful. Some of the changes that we have already undergone in this crisis will certainly have a lasting impact.
What do we know? After the initial shock, many of our clients are already planning the restart of their businesses and experiment with maintaining the newly learned ways of working, mindset and approach. Fortunately, the dynamics of such situations offer opportunities for those that are willing and able to explore their options. While we still do not know what our new normal will look like, nor when we will get there, we have already started embarking on the journey towards a world beyond coronavirus.
Transitioning from a world of the known through a period of unknown can be a leapfrog to transformation. An opportunity which is worth further investigation.
We want to give some rationale and guidance to those who do not want to miss out on potential opportunities, especially opportunities related to “transformation and growth through M&A”. We want to provide an outline on how to implement a successful process that delivers the full expected value of an M&A opportunity during COVID-19 times, even with associated capacity constraints.
Read the full report here:
Get in touch with the authors:
Philipp Ostermeier Managing Director
Dr. Alexander Bock Senior Director
Bob Rajan Managing Director
Medical Device Supply Chains: Disruption Is Permanent. Is the Industry Ready?
June 18, 2026
Medical device supply chains are under increasing pressure as global disruption becomes a constant rather than an exception. From geopolitical volatility to material scarcity and regulatory complexity, the sector now operates in an environment where even minor shocks can have far-reaching consequences. This article explores the structural vulnerabilities shaping today’s MedTech supply networks and highlights why traditional approaches are no longer sufficient. It outlines how leading organisations are rethinking resilience not just as risk mitigation, but as a source of competitive advantage in an increasingly unpredictable world. Download the full article to uncover the strategies that are helping companies respond faster, protect patient outcomes, and maintain operational continuity.
Episode 2: Don Antonucci, President and CEO, Providence Health Plan
June 16, 2026
In this episode, Don Antonucci, President and CEO of Providence Health Plan joins A&M Healthcare Industry Group's Craig Savage and Mike Epstein to share how health plans can maintain stability while delivering value to members.
Building AI from Within at Nebraska Medicine
May 28, 2026
What if the real advantage isn’t buying the latest solution, but building your own? Michael Hasselberg, Chief Transformation and Digital Officer at Nebraska Medicine joins A&M Healthcare Industry Group's Seth Ciabotti and Travis Sherman to share how Nebraska Medicine is building AI capabilities internally—from assembling in-house data science and engineering teams to deploying enterprise tools that address real operational pain points.
Medical Management Is Broken Getting AI Right Will Decide Which Plans Survive
May 7, 2026
AI is reshaping medical management from a cost center into a strategic engine for health plans. In this paper, Managing Directors Bryan Komornik and Craig Savage outline where AI is delivering real value today and how plans can modernize clinical operations to improve cost, quality, and experience.
